Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michelle Kinder

Showing results (11-20 of 16) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 16 results.
Mabs|December 18, 2014
A monoclonal antibody against hinge-cleaved IgG restores effector function to proteolytically-inactivated IgGs in vitro and in vivoRandall J Brezski, Michelle Kinder, Katharine D Grugan, et al.
Immunity|June 24, 2008
The TNF-family receptor DR3 is essential for diverse T cell-mediated inflammatory diseasesFrançoise Meylan, Todd S Davidson, Erin Kahle, et al.
The Journal of Experimental Medicine|September 21, 2011
Type I interferon is selectively required by dendritic cells for immune rejection of tumorsMark S Diamond, Michelle Kinder, Hirokazu Matsushita, et al.
The Journal of Biological Chemistry|August 30, 2013
Engineered protease-resistant antibodies with selectable cell-killing functionsMichelle Kinder, Allison R Greenplate, Katharine D Grugan, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 30, 2012
Tumor-associated macrophages promote invasion while retaining Fc-dependent anti-tumor functionKatharine D Grugan, Francis L McCabe, Michelle Kinder, et al.
Journal for Immunotherapy of Cancer|March 22, 2023
Immune and pathologic responses in patients with localized prostate cancer who received daratumumab (anti-CD38) or edicotinib (CSF-1R inhibitor)Bilal A Siddiqui, Brian F Chapin, Sonali Jindal, et al.
Pageof 2

Showing results (11-20 of 16) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 16 results.
Mabs|December 18, 2014
A monoclonal antibody against hinge-cleaved IgG restores effector function to proteolytically-inactivated IgGs in vitro and in vivoRandall J Brezski, Michelle Kinder, Katharine D Grugan, et al.
Immunity|June 24, 2008
The TNF-family receptor DR3 is essential for diverse T cell-mediated inflammatory diseasesFrançoise Meylan, Todd S Davidson, Erin Kahle, et al.
The Journal of Experimental Medicine|September 21, 2011
Type I interferon is selectively required by dendritic cells for immune rejection of tumorsMark S Diamond, Michelle Kinder, Hirokazu Matsushita, et al.
The Journal of Biological Chemistry|August 30, 2013
Engineered protease-resistant antibodies with selectable cell-killing functionsMichelle Kinder, Allison R Greenplate, Katharine D Grugan, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 30, 2012
Tumor-associated macrophages promote invasion while retaining Fc-dependent anti-tumor functionKatharine D Grugan, Francis L McCabe, Michelle Kinder, et al.
Journal for Immunotherapy of Cancer|March 22, 2023
Immune and pathologic responses in patients with localized prostate cancer who received daratumumab (anti-CD38) or edicotinib (CSF-1R inhibitor)Bilal A Siddiqui, Brian F Chapin, Sonali Jindal, et al.
Pageof 2